Asia-Pacific ECMO Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates) 

No. of Pages: 129    |    Report Code: BMIRE00027899    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia-Pacific ECMO Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia-Pacific ECMO Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia-Pacific ECMO Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. Asia-Pacific ECMO Market Regional Analysis

6.1 Asia-Pacific ECMO Market Overview
6.2 Asia-Pacific ECMO Market Revenue 2020-2028 (US$ Million)
6.3 Asia-Pacific ECMO Market Forecast Analysis

7. Asia-Pacific ECMO Market Analysis – by Modality

7.1 Venoarterial ECMO
  • 7.1.1 Overview
  • 7.1.2 Venoarterial ECMO: Asia-Pacific ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Venovenous ECMO
  • 7.2.1 Overview
  • 7.2.2 Venovenous ECMO: Asia-Pacific ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Arteriovenous ECMO
  • 7.3.1 Overview
  • 7.3.2 Arteriovenous ECMO: Asia-Pacific ECMO Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia-Pacific ECMO Market Analysis – by Application

8.1 Respiratory
  • 8.1.1 Overview
  • 8.1.2 Respiratory: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
  • 8.2.1 Overview
  • 8.2.2 Cardiology: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia-Pacific ECMO Market Analysis – by Age Group

9.1 Adults
  • 9.1.1 Overview
  • 9.1.2 Cardiology: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pediatrics
  • 9.2.1 Overview
  • 9.2.2 Cardiology: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Neonates
  • 9.3.1 Overview
  • 9.3.2 Cardiology: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia-Pacific ECMO Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia-Pacific ECMO Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Asia-Pacific ECMO Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia-Pacific ECMO Market Breakdown, by Modality
    • 10.1.1.1.2 China: Asia-Pacific ECMO Market Breakdown, by Application
    • 10.1.1.1.3 China: Asia-Pacific ECMO Market Breakdown, by Age Group
  • 10.1.1.2 India: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia-Pacific ECMO Market Breakdown, by Modality
    • 10.1.1.2.2 India: Asia-Pacific ECMO Market Breakdown, by Application
    • 10.1.1.2.3 India: Asia-Pacific ECMO Market Breakdown, by Age Group
  • 10.1.1.3 Japan: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia-Pacific ECMO Market Breakdown, by Modality
    • 10.1.1.3.2 Japan: Asia-Pacific ECMO Market Breakdown, by Application
    • 10.1.1.3.3 Japan: Asia-Pacific ECMO Market Breakdown, by Age Group
  • 10.1.1.4 Australia: Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia-Pacific ECMO Market Breakdown, by Modality
    • 10.1.1.4.2 Australia: Asia-Pacific ECMO Market Breakdown, by Application
    • 10.1.1.4.3 Australia: Asia-Pacific ECMO Market Breakdown, by Age Group
  • 10.1.1.5 Rest of Asia-Pacific : Asia-Pacific ECMO Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia-Pacific ECMO Market Breakdown, by Modality
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia-Pacific ECMO Market Breakdown, by Application
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia-Pacific ECMO Market Breakdown, by Age Group

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia-Pacific ECMO Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 ABIOMED Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Braile Biomedica
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eurosets S.R.L.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Fresenius Medical Care AG & Co KGaA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Getinge AB
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 LivaNova Plc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Medtronic Plc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 MicroPort Scientific Corporation
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Nipro Medical Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Terumo Group
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia-Pacific ECMO Market

  1. ABIOMED Inc
  2. Braile Biomedica
  3. Eurosets S.R.L.
  4. Fresenius Medical Care AG & Co KGaA
  5. Getinge AB
  6. LivaNova Plc 
  7. Medtronic Plc
  8. MicroPort Scientific Corporation
  9. Nipro Medical Corporation  
  10. Terumo Group  
asia-pacific-ecmo-market